EmiliaBedelia
Trusted Information Resource
Hoping for some help from any RA people with a photographic memory for FDA guidance documents....
I distinctly remember a guidance document that had a very specific paragraph that described how devices can be marketed/promoted while they are under review in a 510k. I remember this because it specifically stated that new devices under review can be displayed with a statement that they're pending 510k and not available for sale, but existing devices being submitted for a new indication cannot be promoted for this indication, because essentially you can't stop someone from going out and using the device for that use. I used to use this guidance all the time to keep people from saying stuff they shouldn't, but I can't find the reference anymore! There are several guidances/compliance policy guides that cover this topic and essentially say the same thing, but not explicitly. They are pretty clear to me as RA, but... it's not as good as something from the FDA.
I am looking for this specific guidance reference. The best I can find is an MDDI article (https://www.mddionline.com/regulato...roved-medical-devices-according-to-fda-policy) that talks about the same situation, but I am certain that at one point in time there was an FDA document about this.
If nothing else, I hope that someone else remembers this same document and can at least affirm that I'm not making it up!
I distinctly remember a guidance document that had a very specific paragraph that described how devices can be marketed/promoted while they are under review in a 510k. I remember this because it specifically stated that new devices under review can be displayed with a statement that they're pending 510k and not available for sale, but existing devices being submitted for a new indication cannot be promoted for this indication, because essentially you can't stop someone from going out and using the device for that use. I used to use this guidance all the time to keep people from saying stuff they shouldn't, but I can't find the reference anymore! There are several guidances/compliance policy guides that cover this topic and essentially say the same thing, but not explicitly. They are pretty clear to me as RA, but... it's not as good as something from the FDA.
I am looking for this specific guidance reference. The best I can find is an MDDI article (https://www.mddionline.com/regulato...roved-medical-devices-according-to-fda-policy) that talks about the same situation, but I am certain that at one point in time there was an FDA document about this.
If nothing else, I hope that someone else remembers this same document and can at least affirm that I'm not making it up!